Elder Pharmaceuticals Limited - Company Profile

It is a pharma public limited company based in Mumbai, Maharashtra, India, established in 1983.
1983 Mumbai, Maharashtra, India Under Liquidation
Last Updated:
Access Report
About Elder Pharmaceuticals Limited

Elder Pharmaceuticals Limited, a under liquidation public limited company, was established on 02 April 1983 in Mumbai, Maharashtra, India. Engaging in drug formulation & development within the pharma sector, it holds CIN: L24239MH1983PLC029714. Registered under ROC Roc Mumbai. it is listed. It has an authorized capital of ₹30.00 Cr and a paid-up capital of ₹20.54 Cr.

Its leadership includes Kader Mohamed Davawala (Additional Director), Alok Jagdish Saxena (Managing Director), Abdul Khader Mohammed Ravani (Additional Director). Past directors included Peter Charles Bibby, Shrikrishna Pandurang Date, Saleem Iqbal Shervani. It holds ₹338.10 Cr open charges and ₹3,335.92 Cr settled loans. Its latest AGM occurred on 30 December 2013, with the balance sheet filed on 30 June 2013. It is based at Elder House Plot No C9Dalia Industrial Estate Off Veera Desai Road Andheri W India, Mumbai, Maharashtra, 400058.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    L24239MH1983PLC029714

  • Registration Number

    029714

  • Incorporation Date

    02 April 1983

  • Authorized Capital

    ₹30.00 Cr

  • Paid-Up Capital

    ₹20.54 Cr

  • ROC Code

    Roc Mumbai

  • Listing Status

    Listed

  • Company Status

    Under Liquidation

Key Metrics
  • Authorised Capital ₹ 30.00 Cr
  • Paid Up Capital ₹ 20.54 Cr
  • Company Age 42 Year, 10 Months
  • Last Filing with ROC 30 Jun 2013
  • Open Charges ₹ 338.10 Cr
  • Satisfied Charges ₹ 3,335.92 Cr
Company report

Elder Pharmaceuticals Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Elder Pharmaceuticals Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Elder Pharmaceuticals Limited?
Current Directors
Name Designation Appointment Date Status
Kader Mohamed Davawala Additional Director 25 Jan 2016 Current
Alok Jagdish Saxena Managing Director 29 Aug 2002 Current
Abdul Khader Mohammed Ravani Additional Director 25 Jan 2016 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 29 Apr 2009 Past
Pramod Abcsdd Company Secretary 25 Apr 2014 Past
Pramod Abcsdd Director 11 Dec 2014 Past
Pramod Abcsdd Managing Director 10 Oct 2013 Past
Pramod Abcsdd Additional Director 01 Jan 2016 Past
Pramod Abcsdd Director 05 Jun 2014 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Elder Pharmaceuticals.

Enhance accessibility to Elder Pharmaceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Elder Pharmaceuticals revenue growth over time
Elder Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Elder Pharmaceuticals?

Unlock access to Elder Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹3,381,000,000.00

Satisfied Charges

₹33,359,158,008.00

Charges Breakdown by Lending Institutions
  • Axis Trustee Services Limited : 261.80 Cr
  • Bank Of India : 35.00 Cr
  • Axis Bank Limited : 25.00 Cr
  • Dcb Bank Limited : 16.00 Cr
  • Director Of Industries : 0.30 Cr
Latest Charge Details
Date Lender Amount Status
10 Oct 2014 Dcb Bank Limited ₹16.00 Cr Open
30 Jul 2014 Bank Of India ₹35.00 Cr Open
19 Nov 2012 Axis Trustee Services Limited ₹70.00 Cr Open
28 Jun 2011 Axis Trustee Services Limited ₹73.00 Cr Open
21 Mar 2011 Axis Trustee Services Limited ₹118.80 Cr Open

Explore comprehensive loan charge details -

How Many Employees Work at Elder Pharmaceuticals?

Elder Pharmaceuticals has a workforce of 0 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Elder Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Elder Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Elder Pharmaceuticals
Recent Activity within the Organization
  • Director Appointment

    Progress on Kader Mohamed Davawala was appointed as a Additional Director was appointed as a Additional Director on 25 Jan 2016 & has been associated with this company since 10 years 1 month . was documented.

  • Director Appointment

    Progress on Abdul Khader Mohammed Ravani was appointed as a Additional Director was appointed as a Additional Director on 25 Jan 2016 & has been associated with this company since 10 years 1 month . was documented.

  • Charges

    Progress on A charge with Dcb Bank Limited of Rs. 16.00 Cr registered on 10 Oct 2014 with Charge ID 10531139 was modified on 15 Oct 2014. was documented.

  • Charges

    Progress on A charge with Dcb Bank Limited amounted to Rs. 16.00 Cr with Charge ID 10531139 was registered on 10 Oct 2014. was documented.

  • Charges

    The activity A charge registered on 26 Jun 2014 via Charge ID 10504846 with Dbs Bank Ltd was fully satisfied on 19 Aug 2014. was completed.

  • Charges

    The activity A charge with Bank Of India amounted to Rs. 35.00 Cr with Charge ID 10514198 was registered on 30 Jul 2014. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Elder Pharmaceuticals Limited?

The CIN of Elder Pharmaceuticals Limited is L24239MH1983PLC029714.

Where is Elder Pharmaceuticals Limited headquartered?

Elder Pharmaceuticals Limited is headquartered at Elder House Plot No C9Dalia Industrial Estate Off Veera Desai Road Andheri W India, Mumbai, Maharashtra, 400058.

When was Elder Pharmaceuticals Limited incorporated?

Elder Pharmaceuticals Limited was incorporated on 02 April 1983.

Who are the current directors of Elder Pharmaceuticals Limited?

The current directors of Elder Pharmaceuticals Limited are

What is the primary industry of Elder Pharmaceuticals Limited?

The primary industry of Elder Pharmaceuticals Limited is Pharma.

Is Elder Pharmaceuticals Limited a listed company?

Elder Pharmaceuticals Limited is listed.

What is the capital structure of Elder Pharmaceuticals Limited?

The authorized capital of Elder Pharmaceuticals Limited is ₹30.00 Cr, and the paid-up capital is ₹20.54 Cr.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available